Media & Press

Sheila discusses the importance of using machine learning in the early stages of research and development of protein design and medicinal computational chemistry to reduce time and costs and to increase probability of success.

Sheila Gujrathi, a biotechnology entrepreneur and executive, healthcare investor, and drug developer with more than 25 years of experience spoke at Northwestern Engineering's 2024 Undergraduate Convocation on June 10.

Dr. Gujrathi discusses the importance of building a team of people with shared values, the most challenging parts of being a CEO, and how she’s helping to push diversity in biotech forward.

Sheila Gujrathi, MD and Larry Zisman, MD of Gossamer Bio discuss the development of an investigational new treatment for pulmonary arterial hypertension and their Phase 2 Clinical Trial for GB0002.

Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer, speak on the Long Run with Luke Timmerman.